The purpose of this study is to evaluate and compare the Pharmacokinetics/Pharmacodynamics and safety of Remimazolam Tosylate with midazolam in healthy volunteers
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
79
Peking Union Medical College Hospital
Beijing, China
To study the Pharmacokinetics of Remimazolam Tosylate by assessment of drug concentration through blood sample analysis
Time frame: Pre-dose to 8 hours post-dosee
Bispectral index (BIS) and Modified Observer's Assessment of Alertness/Sedation(MOAA/S) score assessments
Time frame: Pre-dose to 2 hours post-dose
Adverse event;Vital sign;Physical examination;Laboratory examination;ECG;The nervous system function test
Time frame: Pre-dose to 24 hours post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.